Cargando…
CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension
Pulmonary arterial hypertension (PAH) is an increasingly frequently diagnosed disease, the molecular mechanisms of which have not been thoroughly investigated. The aim of our study was to investigate subpopulations of lymphocytes to better understand their role in the molecular pathomechanisms of va...
Autores principales: | Tomaszewski, Michał, Małkowska, Paulina, Sierawska, Olga, Hrynkiewicz, Rafał, Mroczek, Ewa, Darocha, Szymon, Hymos, Anna, Błaszczak, Piotr, Grywalska, Ewelina, Niedźwiedzka-Rystwej, Paulina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783197/ https://www.ncbi.nlm.nih.gov/pubmed/36555549 http://dx.doi.org/10.3390/ijms232415910 |
Ejemplares similares
-
Role of the Immune System Elements in Pulmonary Arterial Hypertension
por: Tomaszewski, Michał, et al.
Publicado: (2021) -
The Role of the Immune System in the Development of Endometriosis
por: Abramiuk, Monika, et al.
Publicado: (2022) -
Immunoglobulin Disorders and the Oral Cavity: A Narrative Review
por: Ptasiewicz, Maja, et al.
Publicado: (2022) -
Innate Immune System Response to Burn Damage—Focus on Cytokine Alteration
por: Sierawska, Olga, et al.
Publicado: (2022) -
Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm
por: Niedźwiedzka-Rystwej, Paulina, et al.
Publicado: (2022)